See more : MPIL Corporation Limited (MPILCORPL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Alkem Laboratories Limited (ALKEM.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alkem Laboratories Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- A&D HOLON Holdings Company Limited (7745.T) Income Statement Analysis – Financial Results
- Truett-Hurst, Inc. (THST) Income Statement Analysis – Financial Results
- Banyan Acquisition Corporation (BYN-UN) Income Statement Analysis – Financial Results
- Bertrandt Aktiengesellschaft (BDT.SW) Income Statement Analysis – Financial Results
- Social Leverage Acquisition Corp I (SLAC) Income Statement Analysis – Financial Results
Alkem Laboratories Limited (ALKEM.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.alkemlabs.com
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 126.68B | 115.99B | 105.12B | 87.28B | 81.92B | 72.66B | 63.14B | 56.16B | 49.58B | 37.23B | 27.02B | 23.18B | 19.53B | 16.32B | 13.44B |
| Cost of Revenue | 74.38B | 49.07B | 42.83B | 35.86B | 34.53B | 30.79B | 26.19B | 23.27B | 20.48B | 17.62B | 11.71B | 9.37B | 7.86B | 7.12B | 6.08B |
| Gross Profit | 52.30B | 66.92B | 62.29B | 51.42B | 47.39B | 41.87B | 36.96B | 32.89B | 29.10B | 19.61B | 15.30B | 13.81B | 11.67B | 9.20B | 7.36B |
| Gross Profit Ratio | 41.28% | 57.70% | 59.25% | 58.91% | 57.84% | 57.63% | 58.53% | 58.56% | 58.70% | 52.68% | 56.65% | 59.56% | 59.74% | 56.35% | 54.74% |
| Research & Development | 5.25B | 5.41B | 5.69B | 5.34B | 4.74B | 4.64B | 3.65B | 3.20B | 2.17B | 1.70B | 1.57B | 1.08B | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.03B | 2.99B | 2.48B | 2.23B | 1.69B | 1.70B | 1.28B | 1.36B | 1.31B | 917.90M | 660.19M | 478.65M | 294.54M | 136.61M | 113.52M |
| Selling & Marketing | 12.82B | 13.15B | 10.49B | 6.84B | 8.37B | 7.13B | 6.74B | 5.81B | 5.33B | 4.14B | 3.43B | 2.79B | 2.25B | 1.71B | 1.47B |
| SG&A | 27.61B | 16.14B | 12.97B | 9.06B | 10.06B | 8.83B | 8.02B | 7.17B | 6.64B | 5.06B | 4.09B | 3.27B | 2.55B | 1.85B | 1.59B |
| Other Expenses | 0.00 | 2.16B | 251.20M | 63.80M | 31.90M | 95.00M | 118.90M | 20.80M | 47.60M | 57.10M | 103.98M | 32.95M | 5.33B | 6.21M | 6.19M |
| Operating Expenses | 32.84B | 53.93B | 44.76B | 34.71B | 34.66B | 32.39B | 27.97B | 23.78B | 21.39B | 15.87B | 11.60B | 9.52B | 7.88B | 6.37B | 5.40B |
| Cost & Expenses | 106.16B | 103.00B | 87.59B | 70.57B | 69.19B | 63.18B | 54.16B | 47.05B | 41.87B | 33.49B | 23.31B | 18.90B | 15.74B | 13.49B | 11.48B |
| Interest Income | 2.76B | 1.71B | 1.23B | 901.20M | 631.20M | 412.80M | 787.20M | 1.03B | 1.26B | 1.29B | 1.50B | 1.61B | 1.20B | 959.26M | 504.62M |
| Interest Expense | 1.12B | 1.07B | 408.40M | 488.50M | 542.60M | 497.80M | 504.70M | 388.50M | 643.90M | 784.60M | 825.54M | 776.88M | 522.15M | 103.44M | 138.86M |
| Depreciation & Amortization | 2.99B | 3.10B | 3.04B | 2.75B | 2.53B | 1.93B | 1.43B | 1.01B | 1.01B | 709.40M | 427.30M | 360.15M | 279.40M | 270.46M | 234.31M |
| EBITDA | 24.20B | 17.23B | 21.91B | 21.76B | 15.78B | 11.95B | 11.19B | 11.06B | 10.93B | 6.00B | 5.89B | 6.24B | 5.35B | 4.19B | 2.82B |
| EBITDA Ratio | 19.10% | 15.74% | 20.85% | 23.81% | 19.36% | 16.52% | 18.12% | 19.70% | 20.47% | 16.10% | 21.55% | 26.89% | 26.82% | 23.37% | 20.02% |
| Operating Income | 19.46B | 13.20B | 17.43B | 16.74B | 12.66B | 9.42B | 8.98B | 9.11B | 7.71B | 3.75B | 3.71B | 4.29B | 3.79B | 2.83B | 1.96B |
| Operating Income Ratio | 15.36% | 11.38% | 16.58% | 19.18% | 15.45% | 12.96% | 14.23% | 16.22% | 15.55% | 10.06% | 13.72% | 18.49% | 19.40% | 17.35% | 14.58% |
| Total Other Income/Expenses | 769.40M | -620.60M | -13.63B | -9.33B | -132.30M | 64.80M | 318.70M | 537.20M | -7.32B | -5.09B | 473.35M | 813.91M | 753.64M | 720.23M | 490.88M |
| Income Before Tax | 20.23B | 13.05B | 18.44B | 18.42B | 12.60B | 9.55B | 9.26B | 9.65B | 8.45B | 4.51B | 4.55B | 5.10B | 4.54B | 3.55B | 2.45B |
| Income Before Tax Ratio | 15.97% | 11.25% | 17.54% | 21.10% | 15.38% | 13.14% | 14.66% | 17.18% | 17.05% | 12.11% | 16.85% | 22.00% | 23.26% | 21.76% | 18.24% |
| Income Tax Expense | 2.12B | 2.98B | 1.64B | 2.24B | 1.10B | 1.81B | 2.88B | 599.60M | 1.61B | 592.30M | 110.11M | 137.80M | 289.01M | 251.16M | 100.19M |
| Net Income | 17.96B | 9.84B | 16.46B | 15.85B | 11.27B | 7.61B | 6.31B | 8.92B | 6.73B | 3.92B | 4.44B | 4.96B | 4.25B | 3.30B | 2.35B |
| Net Income Ratio | 14.18% | 8.48% | 15.65% | 18.16% | 13.76% | 10.47% | 9.99% | 15.88% | 13.58% | 10.52% | 16.44% | 21.40% | 21.78% | 20.22% | 17.49% |
| EPS | 150.19 | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 | 52.77 | 74.61 | 62.02 | 32.75 | 36.71 | 41.49 | 35.58 | 27.05 | 19.66 |
| EPS Diluted | 150.19 | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 | 52.77 | 74.61 | 62.02 | 32.75 | 36.71 | 41.49 | 35.58 | 27.05 | 19.66 |
| Weighted Avg Shares Out | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.58M | 119.57M | 119.58M | 119.58M | 119.58M |
| Weighted Avg Shares Out (Dil) | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.57M | 119.58M | 119.58M | 119.58M | 119.58M | 119.58M |
Source: https://incomestatements.info
Category: Stock Reports